ALLO Market Cap & Key Metrics
Allogene Therapeutics, Inc.
$1.36
+$0.06(+4.62%)
30
Overall
60
Value
9
Tech
21
Quality
Market Cap
$449.14M
Volume
1.14M
52W Range
$1.04 - $4.46
Target Price
$8.30
ALLO market cap is $449.14M. This page lists Allogene Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
ALLO Key Metrics
- Market cap
- $449.14M
- EPS estimate, current year
- $-0.59
- EPS growth, 3-year
- +27.89%
- Value score
- 60
- Quality score
- 21
- Technical score
- 9
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | $22.0K | $95.0K | $156.0K | $38.49M |
| EBITDA | -$177.45M | -$243.33M | -$334.68M | -$321.24M | -$169.74M |
| EPS | $-0.87 | $-1.32 | $-2.09 | $-2.32 | $-1.89 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ALLO | $1.36 | +4.6% | 1.14M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Allogene Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW